Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer

BACKGROUND: Identifying optimal chemotherapy utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of adjuvant chemotherapy (ACT) for stage III colon cancer. METHODS: The Ontario Cancer Registry and linked treated records were use...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Karim, Safiya, Booth, Christopher M., Brennan, Kelly, Peng, Yingwei, Siemens, D. Robert, Krzyzanowska, Monika K., Mackillop, William J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745837/
https://ncbi.nlm.nih.gov/pubmed/31407518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars